These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [2nd prize in the competition of works in hepatology GSSR 2010 new approaches to treatment of patients with Nash type 2 diabetes]. V'iuchnova ES; Babina SM Eksp Klin Gastroenterol; 2011; (8):91-6. PubMed ID: 22629763 [No Abstract] [Full Text] [Related]
27. [Definition and management of non-alcoholic steatohepatitis (NASH)]. Hütteroth TH Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S64-7. PubMed ID: 11450617 [No Abstract] [Full Text] [Related]
28. Evaluation and management of non-alcoholic steatohepatitis. Reid BM; Sanyal AJ Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1117-22. PubMed ID: 15489568 [TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic fatty liver disease: an agenda for clinical research. Younossi ZM; Diehl AM; Ong JP Hepatology; 2002 Apr; 35(4):746-52. PubMed ID: 11915019 [No Abstract] [Full Text] [Related]
30. Diagnosis and therapy of nonalcoholic steatohepatitis. Torres DM; Harrison SA Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547 [TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Struben VM; Hespenheide EE; Caldwell SH Am J Med; 2000 Jan; 108(1):9-13. PubMed ID: 11059435 [TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Brunt EM Semin Diagn Pathol; 2005 Nov; 22(4):330-8. PubMed ID: 16939061 [TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Cusi K Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374 [TBL] [Abstract][Full Text] [Related]
35. In search of an ideal biomarker for nonalcoholic fatty liver disease. Bambha K; Yee HF Am J Gastroenterol; 2008 Jun; 103(6):1380-2. PubMed ID: 18510615 [No Abstract] [Full Text] [Related]
36. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Luyckx FH; Lefebvre PJ; Scheen AJ Diabetes Metab; 2000 Apr; 26(2):98-106. PubMed ID: 10804323 [TBL] [Abstract][Full Text] [Related]
37. [Non-alcoholic steatohepatitis]. García Monzón C Gastroenterol Hepatol; 2001 Oct; 24(8):395-402. PubMed ID: 11674960 [No Abstract] [Full Text] [Related]
38. Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus. Menon KVN ; Angulo P; Lindor KD Am J Gastroenterol; 2001 May; 96(5):1631-4. PubMed ID: 11374713 [TBL] [Abstract][Full Text] [Related]
39. [Steatosis and steatohepatitis in diabetic patient]. Hůlek P; Dresslerová I Vnitr Lek; 2011 Apr; 57(4):364-7. PubMed ID: 21612059 [TBL] [Abstract][Full Text] [Related]
40. [Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971]. Schmidt R; Tennstedt A Z Arztl Fortbild (Jena); 1974 Mar; 68(6):298-302. PubMed ID: 4418773 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]